The application must be jointly submitted by a Singapore-registered company and an Israel-registered company. Either company must not have more than 20% shareholding in the partnering company. The joint project must be undertaken in Singapore and Israel. At least 30% of the actual R&D work must be done in Singapore as well as in Israel. Technology and product developed must have potential for commercialization.

How does SIIRD funding work?

The submitted proposals will be subjected to evaluations by independent professionals from Singapore and Israel, after which the evaluated proposals will be submitted to SIIRD Board for approval.

Types of Funding

Feasibility Study – Companies can conduct preliminary investigations to determine the technical feasibility and market acceptability of a new product or process concept. SIIRD can fund up to US$30,000 or 50% of the qualifying costs for conducting feasibility tests, whichever is lower. Such awards are made with the understanding that a formal proposal for a full-scale project will be submitted by the companies, should the feasibility results prove positive.

Mini R&D Project – Companies can embark on joint R&D project where the total qualifying cost is not more than US$400,000 and project duration is not more than one year. SIIRD can fund up to US$200,000 or 50% of the qualifying costs, whichever is lower. This funding type is for companies interested in defining an initial project of modest size rather than plunging into a higher cost full-scale project of longer duration. While the proposal preparation for Mini R&D Project may be less stringent than those associated with a full-scale project, the same criteria regarding business/technical capabilities and commercial potential are applicable. Commercialization is an expected goal for such projects. Once approved, mini-projects are implemented under the same agreements as full-scale projects.

Full-Scale R&D Project – For joint R&D project of larger scale where the maximum project duration is three years, SIIRD can fund up to 50% of the qualifying costs or between US$200,000 and US$1,000,000 (not more than US$500,000 in one year), whichever is lower. Commercialization is also an expected goal for full scale R&D projects.